Tag: 64x Bio


Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech

January 19, 2022

Via: FiercePharma

64x Bio, a fledgling synthetic cell and gene therapy manufacturer, brought in $55 million in a series A round of fundraising. The company, which has about 10 employees and was founded in 2020 out of the Harvard Department of Genetics, […]